Classifying Glioma via Liquid Biopsy: Progress toward an Unmet Clinical Need.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38652677.
- Also identified by DOI 10.1158/1078-0432.CCR-24-0423.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The diagnosis and classification of glioma by liquid biopsy represent a critical unmet need in neuro-oncology. A recent study demonstrates targeted next-generation sequencing of cell-free DNA from cerebrospinal fluid as an evolving option for liquid biopsy in patients with glioma. See related article by Iser et al., p. 2974.
Medical subject headings
- Glioma
- Biomarkers, Tumor
- High-Throughput Nucleotide Sequencing
- Brain Neoplasms
- Cell-Free Nucleic Acids